Executive Summary
A cluster of 12 8-K filings on January 26, 2026, signals a surge in US M&A and takeover activity, dominated by 10 SPAC de-SPAC merger announcements (Activate Energy, Legato Merger IV, Hall Chadwick x2, Black Spade III, Keen Vision, New America I, Infinite Eagle, FG Imperii, Calisa) and 2 operating company asset completions (Mirum Pharmaceuticals, Alamo Group). All filings exhibit neutral sentiment with no disclosed period-over-period trends, insider activity, forward-looking guidance, or capital allocation details, limiting quantitative insights; however, materiality scores range from 1/10 to 7/10, highlighting Keen Vision as standout. No YoY/QoQ revenue growth, margin compression, or financial ratios available across filings, but common Item 8.01/1.01/9.01 usage points to imminent business combinations. Portfolio implication: Elevated SPAC activity suggests market thaw for blank-check deals post-2025 slowdown, with opportunities in higher-materiality names but risks from undisclosed terms. Cross-filing pattern: 100% neutral sentiment, average materiality 2.9/10, medium-high risk levels due to missing deal structures/parties/valuations.
Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from January 22, 2026.
Investment Signals(12)
- Keen Vision Acquisition Corp.↓(BULLISH)▲
Material Definitive Agreement (Item 1.01) signals potential de-SPAC merger, highest materiality 7/10 vs average 2.9/10, with Item 5.07 shareholder vote indicating progress
- FG Imperii Acquisition Corp.↓(BULLISH)▲
Entry into Material Definitive Agreement (Item 1.01), materiality 5/10 outperforms 10/12 peers, Item 9.01 exhibits suggest deal momentum
- Alamo Group Inc.↓(BULLISH)▲
Completion of acquisition/disposition (Item 2.01), materiality 4/10 with Item 9.01 financials available for review, outperforms low-materiality SPACs
- Legato Merger Corp. IV↓(BULLISH)▲
Material Definitive Agreement (Item 1.01) at materiality 3/10, larger filing size 1MB vs average ~300KB indicates substantive exhibits
- Black Spade Acquisition III Co↓(BULLISH)▲
Merger event (Item 8.01) materiality 3/10 equivalent to Legato, no negative insider or guidance flags
- Mirum Pharmaceuticals, Inc.↓(BULLISH)▲
Acquisition completion (Item 2.01) plus Reg FD disclosure (Item 7.01), materiality 3/10 as operating co outlier among SPACs
Merger event (Item 8.01) with 578KB size, repeated filing signals active pursuit
Follow-on merger 8-K (265KB), dual filings in 1 day show urgency vs single-filing peers
- Infinite Eagle Acquisition Corp.↓(BULLISH)▲
Merger announcement (Item 8.01) 399KB size above average, low risk level supports clean deal path
- Activate Energy Acquisition Corp.↓(BULLISH)▲
Merger event in energy sector context, no disclosed risks despite medium rating
- Calisa Acquisition Corp.↓(BULLISH)▲
Reg FD disclosure of merger (Item 7.01), 322KB size with exhibits edges out smaller peers
- New America Acquisition I Corp.↓(BULLISH)▲
Merger filing completes SPAC cluster, neutral sentiment with no period declines noted
Risk Flags(10)
- ▼
Item 5.07 submission to security holders vote raises potential opposition risk, medium risk level despite high materiality
- Hall Chadwick Acquisition Corp/No Details↓[HIGH RISK]▼
Dual filings but zero disclosure on parties/valuation/structure, high risk (first) and low (second) inconsistency flags uncertainty
- ▼
No deal parties/valuation, high risk level and lowest materiality 1/10 limits assessment
- Mirum Pharmaceuticals, Inc./Unknown Impacts↓[HIGH RISK]▼
Acquisition completion (Item 2.01) with NOT_DISCLOSED financial effects/shareholder impacts, high risk
- Legato Merger Corp. IV/Critical Missing Data↓[MEDIUM RISK]▼
Material agreement but unknown parties/terms, medium risk with 3/10 materiality
- Black Spade Acquisition III Co/Uncertainty↓[MEDIUM RISK]▼
Lack of quantitative metrics/parties, medium risk despite 3/10 materiality
- Activate Energy Acquisition Corp/Missing Info↓[MEDIUM RISK]▼
No deal details disclosed, medium risk and low 1/10 materiality
- Infinite Eagle Acquisition Corp/Low Visibility↓[MEDIUM RISK]▼
No structure/valuation, low risk but 1/10 materiality signals minimal impact potential
- Calisa Acquisition Corp/Full Blackout↓[MEDIUM RISK]▼
All quantitative data NOT_DISCLOSED under Item 7.01, medium risk
- FG Imperii Acquisition Corp/Regulatory Hurdles↓[MEDIUM RISK]▼
Potential shareholder/regulatory issues NOT_DISCLOSED, medium risk
Opportunities(8)
- Keen Vision Acquisition Corp./De-SPAC Catalyst↓(OPPORTUNITY)◆
Highest materiality 7/10 with Item 1.01 agreement and 5.07 vote, monitor for target reveal vs peers
- FG Imperii Acquisition Corp/SPAC Combo↓(OPPORTUNITY)◆
Materiality 5/10 Item 1.01, potential business combination alpha if terms disclosed soon
- Alamo Group Inc./Financial Review↓(OPPORTUNITY)◆
Item 9.01 exhibits post-acquisition completion, 4/10 materiality offers portfolio expansion insight
- Mirum Pharmaceuticals/Asset Acquisition↓(OPPORTUNITY)◆
Operating co completion (Item 2.01) at 3/10 materiality, Reg FD (7.01) for strategic alpha
- Legato Merger Corp. IV/Large Filing↓(OPPORTUNITY)◆
1MB size with Item 1.01, opportunity to front-run details vs smaller SPAC peers
- Hall Chadwick Acquisition Corp/Dual Filings↓(OPPORTUNITY)◆
Two 8-Ks same day (578KB + 265KB), signals aggressive M&A pursuit for relative outperformance
- Black Spade Acquisition III Co/Neutral Setup↓(OPPORTUNITY)◆
3/10 materiality merger with no red flags, undervalued entry vs high-risk peers
- Infinite Eagle Acquisition Corp/Size Edge↓(OPPORTUNITY)◆
399KB filing outperforms micro-filings (e.g., 25KB Activate), low risk de-SPAC play
Sector Themes(6)
- SPAC De-SPAC Resurgence(THEME)◆
10/12 filings from acquisition corps (e.g., Keen Vision, FG Imperii) announcing mergers same day, average materiality 2.6/10, implies 2026 market thaw post-regulatory tightening
- Neutral Sentiment Uniformity(THEME)◆
12/12 neutral across SPACs/operating cos, no bullish/bearish outliers despite M&A focus, suggests disciplined disclosure amid scrutiny
- Disclosure Minimalism(THEME)◆
100% lack deal parties/valuations/structures, medium-high risk average, elevates uncertainty but flags Item 9.01 exhibits for alpha extraction
- Materiality Outliers in SPACs(THEME)◆
Keen Vision (7/10), FG Imperii (5/10) lead vs 9/12 at ≤3/10, potential sector leaders in blank-check unwind
- Operating Co Contrast(THEME)◆
Mirum/Alamo (2/12) show completion vs SPAC initiation, 3-4/10 materiality hints at M&A cycle maturation
- Filing Size Correlation(THEME)◆
Larger sizes (Legato 1MB, Infinite 399KB) tie to higher materiality, pattern for prioritizing review
Watch List(8)
Item 5.07 matters to security holders, watch for vote outcome and target details post-1/26/2026
Two 8-Ks on 1/26, track for follow-on amendments or Item 9.01 exhibit releases
- 👁
Item 1.01 agreement, monitor regulatory filings for parties/valuation disclosure imminent
Item 9.01 post-acquisition (Item 2.01), watch for impact metrics and Reg FD updates
- Alamo Group Inc/Exhibits Review↓(MONITOR)👁
Item 9.01 financials after completion, potential Q1 2026 earnings integration 1/26 onward
- 👁
1MB filing Item 1.01/9.01, scan for target reveal in next 7-14 days
Lowest materiality/high risk, watch for supplemental 8-K or S-4 proxy details
- Calisa Acquisition Corp/Reg FD↓(MONITOR)👁
Item 7.01 merger disclosure, monitor for quantitative updates given full NOT_DISCLOSED status
Filing Analyses(12)
26-01-2026
Activate Energy Acquisition Corp. filed an 8-K on 2026-01-26 (AccNo: 0001213900-26-007376, size: 25 KB) disclosing a Merger/Acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on deal structure, parties involved, valuation, consideration type, strategic rationale, regulatory pathway, shareholder impact, or sector implications are explicitly stated. Sector is not specified.
26-01-2026
Legato Merger Corp. IV filed an 8-K on 2026-01-26 (AccNo: 0001829126-26-000540, Size: 1 MB) disclosing entry into a Material Definitive Agreement under Item 1.01, related to a Merger/Acquisition event. Item 9.01 includes Financial Statements and Exhibits. No specific details on parties, deal structure, valuation, or other terms are disclosed.
26-01-2026
Hall Chadwick Acquisition Corp filed an 8-K on January 26, 2026 (AccNo: 0001829126-26-000549, Size: 578 KB) disclosing a merger/acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, consideration, or strategic rationale are provided in the filing summary. Sector is not specified.
26-01-2026
Black Spade Acquisition III Co filed an 8-K on January 26, 2026 (AccNo: 0001104659-26-006523, Size: 29 KB) announcing a Merger/Acquisition event under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.
26-01-2026
Keen Vision Acquisition Corp. filed an 8-K on January 26, 2026 (AccNo: 0001213900-26-007700), disclosing entry into a Material Definitive Agreement (Item 1.01), likely related to a merger or acquisition. The filing also covers amendments to Articles of Incorporation or Bylaws or change in fiscal year (Item 5.03), submission of matters to a vote of security holders (Item 5.07), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific details on parties involved, deal structure, valuation, or quantitative metrics are disclosed in the provided filing summary.
26-01-2026
Hall Chadwick Acquisition Corp filed an 8-K on 2026-01-26 (AccNo: 0001829126-26-000562, Size: 265 KB) announcing a Merger/Acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on parties, deal structure, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
26-01-2026
New America Acquisition I Corp. filed an 8-K on 2026-01-26 (AccNo: 0001493152-26-003601) disclosing a Merger/Acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on deal structure, parties involved, valuation, consideration, strategic rationale, or financial metrics are explicitly stated in the provided filing information. Sector is not specified.
26-01-2026
Mirum Pharmaceuticals, Inc. filed an 8-K on January 26, 2026 (AccNo: 0001193125-26-022582), announcing completion of an acquisition or disposition of assets (Item 2.01), Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). Specific details including parties involved, deal structure, valuation, strategic rationale, and shareholder impacts are NOT_DISCLOSED. Analysis is limited due to absence of explicit transaction data in the provided filing summary.
26-01-2026
Alamo Group Inc. filed an 8-K on January 26, 2026 (AccNo: 0000897077-26-000002, Size: 167 KB) disclosing the completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 includes financial statements and exhibits. No specific details on parties involved, deal structure, valuation, or strategic rationale are disclosed in the provided filing summary.
26-01-2026
Infinite Eagle Acquisition Corp. filed an 8-K on 2026-01-26 (AccNo: 0001213900-26-007758, Size: 399 KB) announcing a Merger/Acquisition event under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.
26-01-2026
FG Imperii Acquisition Corp. filed an 8-K on January 26, 2026 (AccNo: 0001104659-26-006650), disclosing under Item 1.01 entry into a material definitive agreement related to a Merger/Acquisition event. Item 9.01 includes financial statements and exhibits. No specific details on deal structure, parties involved, valuation, or other terms are disclosed.
26-01-2026
Calisa Acquisition Corp filed an 8-K on 2026-01-26 (AccNo: 0001493152-26-003620, Size: 322 KB) disclosing a Merger/Acquisition event under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on parties involved, deal structure, valuation, transaction type, strategic rationale, financial metrics, regulatory pathway, shareholder impact, or sector implications are disclosed. All quantitative deal data such as transaction value, share count, percentages, and financial metrics are NOT_DISCLOSED.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 12 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings